AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 146 filers reported holding AKEBIA THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 0.06 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $129,790,000 | -68.2% | 180,790 | 0.0% | 0.00% | – |
| Q4 2021 | $408,585,000 | -18.5% | 180,790 | +3.8% | 0.00% | – |
| Q3 2021 | $501,619,000 | -33.4% | 174,173 | -12.4% | 0.00% | – |
| Q2 2021 | $753,224,000 | +138.2% | 198,740 | +112.7% | 0.00% | – |
| Q1 2021 | $316,220,000 | +28.2% | 93,418 | +6.1% | 0.00% | – |
| Q4 2020 | $246,624,000 | +11.6% | 88,080 | 0.0% | 0.00% | – |
| Q3 2020 | $221,081,000 | -81.7% | 88,080 | -1.2% | 0.00% | -100.0% |
| Q2 2020 | $1,211,160,000 | +101.9% | 89,187 | +12.7% | 0.00% | – |
| Q1 2020 | $599,797,000 | +13.7% | 79,129 | -5.2% | 0.00% | – |
| Q4 2019 | $527,588,000 | +67.6% | 83,479 | +3.9% | 0.00% | – |
| Q3 2019 | $314,811,000 | -13.1% | 80,309 | +7.3% | 0.00% | – |
| Q2 2019 | $362,182,000 | -30.4% | 74,831 | +17.8% | 0.00% | – |
| Q1 2019 | $520,212,000 | +131.1% | 63,518 | +56.0% | 0.00% | – |
| Q4 2018 | $225,137,000 | +43.2% | 40,712 | +128.7% | 0.00% | – |
| Q3 2018 | $157,174,000 | -11.5% | 17,800 | 0.0% | 0.00% | – |
| Q2 2018 | $177,644,000 | +4.7% | 17,800 | 0.0% | 0.00% | – |
| Q1 2018 | $169,634,000 | – | 17,800 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $10,515,000 | 10.70% |
| Orchard Capital Management, LLC | 1,593,531 | $3,601,000 | 1.06% |
| Nantahala Capital Management | 4,918,565 | $11,116,000 | 0.39% |
| Ardent Capital Management, Inc. | 168,811 | $382,000 | 0.25% |
| Birchview Capital, LP | 100,000 | $226,000 | 0.15% |
| Nantahala Capital Management | 1,000,000 | $2,260,000 | 0.08% |
| PDT Partners, LLC | 433,400 | $979,000 | 0.08% |
| Woodline Partners LP | 2,231,966 | $5,044,000 | 0.07% |
| Virtus ETF Advisers LLC | 69,015 | $156,000 | 0.06% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 2,737,900 | $6,188,000 | 0.04% |